Therataxis
Stage
Incubator/Accelerator | AliveAbout Therataxis
Therataxis LLC models brain transport processes and designs delivery methods for therapies. The simulation and prediction of transport mechanisms, and their direct delivery devices, provide the necessary link in developing successful therapies of the brain by ensuring proper delivery. Their currently marketed products are surgical simulation software and simulation-based device designs.
Missing: Therataxis's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Therataxis's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Therataxis Patents
Therataxis has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/12/2010 | 11/12/2013 | Acoustics, Waves, Fluid dynamics, Wave mechanics, Porous media | Grant |
Application Date | 11/12/2010 |
|---|---|
Grant Date | 11/12/2013 |
Title | |
Related Topics | Acoustics, Waves, Fluid dynamics, Wave mechanics, Porous media |
Status | Grant |
Latest Therataxis News
Sep 4, 2013
Scott & White Memorial Hospital in Temple, Texas, has received a $1 million grant in partnership with Twin Star Medical Inc. and Therataxis Inc. to conduct research in an alternative delivery system to treat prostate cancer. The grant from the National Institute of Health will focus on the use of a hollow microfiber catheter to inject therapy drugs into the prostate to treat both benign and malignant cases. Scott & White’s urology department will handle the administration of the treatme
Therataxis Frequently Asked Questions (FAQ)
Where is Therataxis's headquarters?
Therataxis's headquarters is located at Baltimore.
What is Therataxis's latest funding round?
Therataxis's latest funding round is Incubator/Accelerator.
Who are the investors of Therataxis?
Investors of Therataxis include Emerging Technology Center.
Who are Therataxis's competitors?
Competitors of Therataxis include Mirus Bio, Impel NeuroPharma, Corium International, Vapore, Edge Therapeutics and 11 more.
Compare Therataxis to Competitors
Iontera, formerly Isis Biopolymer, designs and develops intelligent transdermal drug delivery (TDD). TDD has long held the promise of non-invasive drug delivery, adding convenience, reduced costs and improved patient compliance via the application of a patch to the skin. The missing components in TDD have been controlled release of the drug carried in the patch and the breadth of drugs that can actually be transferred though skin. Iontera's patented IonIQ technology intelligently enhances and controls delivery via a single-electrode design that is governed by a programmable on-board computer.
Vapore is the developer of MyPurMist, a device that provides soothing hot steam on demand. The directed humidification (vapor) of MyPurMist brings warmth into the sinuses which thins mucus and makes breathing easier. The moisture in the mist helps to relieve symptoms by soothing irritated tissues in the nose and throat, calming coughs and reducing dryness.
Tandem is a medical device company located in San Diego. The company manufactures and sells an automated drug delivery system primarily for use in home-administered IV's. The device is a relatively simple mechanical pump that is simpler and safer to use than standard IV therapy.
Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.
Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibility Studies, Prototype Development, Formulation Optimization, Clinical Trials, Regulatory Compliance, Process Scale-up, and Full Scale Manufacturing.
Iaculor Injection Inc. develops low cost, more efficient needle-free injection devices that allow the delivery of powder or liquid forms of vaccines, small molecules and biologicals.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.